Ashleigh Shannon, PhD
Postdoctoral Researcher, Aix Marseille University
Zooming in on SARS-CoV-2 Replication to Develop Antiviral Therapies
Antiviral drugs that slow SARS-CoV-2 replication in patient cells are critical for curbing the pandemic. For RNA viruses such as SARS-CoV-2, genome duplication hinges on RNA polymerase, making the enzyme an ideal therapeutic target for drug development.